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ABSTRACT 
Guduchyadi kwatham is a renowned Ayurvedic formulation used by Ayurvedic physicians all over 
India against influenza attacks and viral diseases. It is indicated for Pitta and Kapha aggravated 
conditions, Jwaram (Fever) and diseases of gastrointestinal system in classical Ayurvedic 
literature. Indications and pharmacological activities of the ingredients in respiratory diseases 
and Rakta (Blood) vitiated conditions suggest the use of this formulation in viral diseases that 
mainly involve respiratory system. In order to assess the pharmacological potential, Ayurvedic 
literature of the formulation and the pharmacological evaluations conducted with the part used 
and phytoconstituents of individual drugs were collected. Informations about the pathogenesis 
and symptomatology of COVID-19 were gathered from the recent research publications which 
were available online. Common symptoms of Coronavirus disease 2019 caused by severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2) are fever, cough, sputum production, fatigue, 
headache, haemoptysis, diarrhoea, dyspnoea, and lymphopenia. When the disease progresses 
clinical conditions like Pneumonia, RNAaemia, acute respiratory distress syndrome, etc that lead 
to may develop death. Significantly increased level of leukocytes, pro-inflammatory cytokines and 
chemokines in plasma are seen during pathogenesis. The manifestation of systemic inflammatory 
response along with respiratory symptoms reveals that the main Doshas involved in this viral 
infection are Pitta and Kapha. The formulation possesses Pittakapha samana action and the 
ingredients are beneficial in diseases of Pranavahasrotas, Annavahasrotas, Rasavahasrotas and 
Raktavahasrotas. Pharmacological screening of drugs demonstrated anti-inflammatory, 
antipyretic, antiviral, antibacterial, anti allergic, antioxidant and immunomodulatory effects. 
Ayurvedic literature and findings of various phytochemical and pharmacological researches 
validate the use of Guduchyadi kwatham in the prevention and mitigation of this viral disease. 
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INTRODUCTION 
Guduchyadi kwatham is an Ayurvedic 
formulation prepared out of the drugs mentioned in 
Guduchyadi ganam described in one of the important 
classical Ayurvedic text Ashtangahridayam in the 
section Sutrasthanam 15th Chapter.[1] Guduchyadi 
ganam is also cited in the text Ashtangasamgraham in 
the same section.[2] It is a renowned pharmaceutical 
preparation suggested by Ayurvedic physicians of 
Kerala against manifestation of viral diseases. 
Classical indications in literature advise the use of 
this medicine in Pitta and Kapha aggravated 
conditions, Jwaram (Fever) and diseases of 
gastrointestinal system.[1,2] Indications of the 
ingredients suggest the use in diseases of respiratory 
system and Rakta (Blood) vitiated conditions. 
Guduchyadi kwatham is extensively used in influenza 
attack and various hepatic viral infections by 
Ayurvedic practitioners all over India. It has also 
been used in different stage of HIV, Dengue fever and 
H1N1 infection. Various pharmacological and 
biological activities reported by the drugs supports 
the use of this formulation in viral diseases that affect 
respiratory system. 
MATERIALS AND METHODS 
Relevant sections of Samhitas and Nighantus 
were referred to collect the Ayurvedic literature 
relating to the formulation and ingredients of 
Guduchyadi kwatham. Pharmacological evaluations 
conducted with the part used and phytoconstituents 
of individual drugs were collected from the research 
articles available online mainly through PubMed 
search engine. Important phytoconstituents that 
were screened for pharmacological actions were 
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selected after comprehensive evaluation of the 
available literature.  
Pipeline pharmacological activites considered 
were Anti viral, Anti-Dengue, Anti-HIV, Anti-Malarial, 
Anti-inflammatory, Antipyretic, Analgesic, Anti-
bacterial, Anti-tubercular, Anti-allergic, Antioxidant 
and Immunomodulatory. Gastroprotective, Hepato-
protective and Cardio-protective activites of the 
drugs were evaluated to assess the benefit of the 
drugs in organ specific pathologies. Diseases such as 
Diabetes, Hyperlipidaemia, Cancer, Anxiety and 
Depression were considered to get the advantage in 
comorbid conditions. In vitro, in vivo and clinical 
studies conducted with aqueous extract were opted 
for correlation with dosage form i.e., Kwatham of the 
medicine. If such studies were not available results of 
various extracts were selected.  
Ingredients of Guduchyadi Kwatham 
1. Guduchi- Tinospora cordifolia (Willd.) Miers ex 
Hook.f. & Thoms. 
2. Padmaka- Caesalpinia sappan Linn./ Prunus 
cerasoides D.Don 
3. Aristha- Azadirachta indica. A. Juss 
4. Dhanyaka- Coriandrum sativum Linn 
5. Raktachandana- Pterocarpus santalinus Linn. f 
Indications of Guduchyadi Kwatham 
Guduchyadi kwatham is indicated in the following 
conditions or diseases.[1,2] 
1. As a Deepana drug - With Appetizer action  
2. Pithakaphajaroga – Diseases due to Pitta and 
Kapha Dosa vitiation. 
3. Jwara - Fever 
4. Chardi- Vomitting 
5. Daham- Burning sensation 
6. Trishna- Thirst  
Drugs with Botanical Source and Parts Used 
Table 1: Botanical name of drugs with Family and Parts used in Guduchyadi kwatham 
Drugs Botanical name Family Part used 
Guduchi Tinospora cordifolia (Willd.) Miers ex Hook.f. & Thoms. Menispermaceae Stem 
Padmaka Prunus cerasoides D. Don (Ayurvedic Pharmacopoeia of 
India)/ Caesalpinia sappan Linn. (used in Kerala) 
Rosaceae 
Caesalpiniaceae  
Heartwood 
Arishta Azadirachta indica A. Juss Meliaceae Stem bark 
Dhanyaka Coriandrum sativum Linn Umbelliferae Fruit 
Raktachandana Pterocarpus santalinus Linn. f Fabaceae Heartwood 
Method of Preparation 
Take 12gm of each drug, wash well and dry. Then crush the raw drugs well. Put the entire material in 
1.5 litres of water taken in an earthern pot and boil in low flame till it reduces to 180ml. Then filter and use as 
gently warm Kwatham. 
Dose  
90ml Kwatham morning and evening one hour before food or as prescribed by the physician.  
Pharmacological Properties (Rasadi Gunas) of the Drugs 
Pharmacological properties of the drugs described in Ayurvedic classics reveal that most of the drugs 
are Kashaya (astringent) and Tikta (bitter) predominat in Rasa (taste) and Laghu (light) in Guna (quality). 
Veerya (potency) of the drugs varies as Ushna (hot) or Seetha (cold) and Vipaka (post-digestive taste) as 
Madhuram (sweet) or Katu (acrid).[1] 
Table 2: Ayurvedic Pharmacological properties of drugs in Guduchyadi kwatham 
Drug Rasam (Taste)  Gunam 
(Quality)  
Veeryam 
(Potency) 
Vipakam (Post-
digestive taste) 
Guduchi Kashayam, Tiktam, Katu, Madhuram Laghu Ushnam Madhuram 
Padmaka Kashayam, Tiktam Laghu Seetam  
Arista Tikta, Katu Laghu Seetam Katu 
Dhanyaka Kashayam, Tiktam, Madhuram Snigdham, Laghu Ushnam Madhuram 
Raktachandana Tiktam, Madhuram Guru Seetam Katu 
Note: Madhuram– Sweeet; Tiktam– Bitter; Katu– Acrid; Kashayam- Astringent 
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Pharmacological Actions (Karmam) of the Drugs 
A. Actions on Body constituents (Dosha (Bio-regulatory principle), Dhatu (Structure) and Malam 
(Excretory product) 
Drugs in Guduchyadi kwatham are useful in Ekadoshaja (that involves one Dosha), Dwidoshaja (that 
involve two Doshas) and Tridoshaja (that involve three Doshas) vitiated conditions. Guduchi, Padmaka and 
Raktachandana are advised for Dosha vitiation associated with Rakta (Blood). Raktachandana increases semen 
and possess powerful blood purifying activity. Guduchi has fat diminishing action. Dhanyaka increases urine, 
obstructs faeces and helps in removing foul smell of body.[3] 
Table 3: Pharmacological actions of drugs in Dosha, Dhatu and Malam 
I. Action on Doshas 
1 Guduchi Pacifying actions 
Ekadoshajam  Pitta visoshanam (diminish Pitta) 
Dwidoshajam  
 
Kaphavatakhnam (eliminate Kapha and Vata) 
Vatapittanut (remove Vata and Pitta) 
Rakta vata prasamanam (pacify Rakta and Vata) 
Tridoshajam Tridosha haram (destroy Vata, Pitta and Kapha) 
2 Padmaka Pacifying actions 
Ekadoshajam  Vatanut (remove Vata) 
Dwidoshajam  
 
Pittakaphaharam (destroy Pitta and Kapha) 
Raktapittakhnam (eliminate Rakta and Pitta) 
Tridoshajam  Sleshmaasrapittanut (remove Kapha, Rakta and 
Pitta) 
Aggravating actions 
Ekadoshajam Vatalam (increases Vata) 
3 Arishta Pacifying actions 
Ekadoshajam  Kaphasaanti (soothes Kapha) 
Pittadosahjit (wins Pitta) 
Balasabhid (breaks Kapha) 
Tridoshajam Sleshmaasrapittanut (remove Kapha, Rakta and 
Pitta) 
4 Dhanyaka Pacifying actions 
Ekadoshajam  Pittanasanam (eradicate Pitta) 
Kaphaharam (destroy Kapha) 
Tridoshajam Tridoshanut (remove Vata, Pitta and Kapha) 
5 Raktachandana Pacifying actions 
Dwidoshajam  Asrapittahrit (destroy Rakta and Pitta) 
Pittakaphajit (win Pitta and Kapha) 
II. Action on Dhatus 
1 Guduchi Medo vishoshanam (diminish Medas - Fat) 
5 Raktachandana Visheshat raktasudhikrit (especially purifies Blood) 
Sukralam (increases Sukra - Semen) 
III. Action on Malas 
4 Dhanyaka Mootralam (increases urine) 
Dourgandhyanasanam (eradicate foul smell) 
Badhavidkam (obstructs feces) 
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B. Actions on Metabolic functions (Agni and Amam) 
 Guduchi, Arishta and Dhanyaka possess action on Agni and increases digestive fire. Guduchi and 
Dhanyaka helps in the digestion of Amam also ie, the vitiated Rasa formed during digestion.[3] 
Table 4: Pharmacological actions of drugs in Agni and Amam 
I. Action on Agni (Digestive fire) 
1 Guduchi Agnideepani (increases digestive fire) 
3 Arishta Agnikrit (produces digestive fire) 
4 Dhanyaka Deepanam (increases digestive fire) 
II. Action on Amam 
1 Guduchi Ama haram (destroy Ama - vitiated Rasa formed during digestion) 
4 Dhanyaka Pachanam (digests Ama) 
C. Actions on Sense organs and Mental faculties (Indriyam and Budhi) 
 Drug, Dhanyaka is good for enhancing the taste of food. More over Dhanyaka and Raktachandana are 
beneficial for improving the functions of eyes and vision. Guduchi helps in improving the mental power.[3] 
Table 5: Pharmacological actions of drugs in Indriyam and Budhi 
I. Action on Indriyam (Sense organs) 
4 Dhanyaka Rochanam (produces Taste) 
Chakshusyam (beneficial for vision) 
5 Raktachandana Netrahitam (favorable for eyes) 
Chakshusyam (beneficial for vision) 
II. Action on Budhi (Intellect) 
1 Guduchi Medhyam (improves mental power) 
D. Action on Organs and Body (Sthanam, Avayavam and Sarva Sareeram) 
Padmaka is a drug that protects the foetus specifically. Arishta and Raktachandana help in healing 
ulcers. Guduchi and Dhanyaka are reported as beneficial for the health of heart. All the drugs except 
Raktachandana dries up the unwanted fluid produced in the body. Guduchi and Raktachandana promotes the 
strength of the body and Padmaka and Raktachandana improves vigor and sexual desire. Guduchi is supportive 
to life. Raktachandana possess Rakshokhna property ie, protects from disease manifestation. 
Table 6: Pharmacological actions of drugs in Sthanam, Avayavam and Sarva Sareeram 
I. Action on Sthanam (Site) 
2 Padmaka Garbha Samsthapanam (sustains pregnancy specifically) 
Garbha Sthairyakaram (gives stability to pregnancy) 
3 Arishta Vranavisodhanam (cleanse wound specifically) 
Sophapakakaram (inflames odoema) 
5 Raktachandana Vranyam (beneficial for healing ulcer) 
II. Action on Avayavam (Organ) 
1 Guduchi Hridyam (beneficial to Heart) 
3 Arishta Ahridyam (not beneficial to Heart) 
4 Dhanyaka Hridyam (beneficial to Heart) 
III. Action on Sarva Sareeram (Whole body) 
1 Guduchi Samgrahi (dries up fluid specifically) 
Balyam (produces strength)  
Ayushyam (beneficial to life) 
Rasayanam (prevents old age and disease manifestation) 
2 Padmaka Grahi (dries up fluid) 
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Vrishyam (improves vigor and sexual desire) 
3 Arishta Grahi (dries up fluid) 
4 Dhanyaka Grahi (dries up fluid) 
Avrishyam (not improves vigor and sexual desire) 
5 Raktachandana Rakshokhnam (protects from disease manifestation) 
Balyam (produces strength) 
Vrishyam (improves vigor and sexual desire) 
Therapeutic Indications of Drugs 
The drugs of Guduchyadi kwatham are useful in the diseases of Pranavahasrotas (Respiratory system), 
Udakavahasrotas (Channels of fluid), Annavahasrotas (Gastrointestinal system), Rasavahasrotas (Plasma and 
Lymphatic system), Raktavahasrotas (Blood and Cardiovascular system), Mamsavahasrotas (Muscular tissue) 
and Medovahasrotas (Adipose tissue), disorders due to extremely vitiated Pitta, toxic conditions and agony due 
to the disease. Raktachandana is specified for its use against microorganisms. All the above drugs are also 
indicated for the diseases due to exogenous pathogens.[3]  
Indications of respiratory diseases include cough and dyspnoea. Important clinical features of 
gastrointestinal system comprise of vomiting, loss of taste, nausea and Amam or vitiated Rasa formed during 
digestion due to lack of digestive fire. 
Table 7: Therapeutic indications of drugs in Guduchyadi kwatham 
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I. Nija vikaras (Endogenous diseases) 
a. Doshic condition 
Pittadosham (Disorders due to vitiated Pitta) - - Y - - 
Sudaruna pittakopam (Disorders due to extremely 
vitiated Pitta) 
- - - - Y 
b. Diseases of Pranavahasrotas 
Kasam (Cough) Y - Y Y - 
Kaphapittakasam (Cough due to Kapha and Pitta 
predominance) 
- - - - Y 
Swasam (Dyspnoea) - - Y Y - 
c. Udkavahasrotas 
Trid (Thirst) Y Y Y Y Y 
Daham (Burning sensation) Y Y Y Y - 
d. Annavahasrotas 
Chardhi (Vomiting) Y Y Y Y Y 
Aruchi (Loss of taste) - - Y - - 
Hrillasam (Nausea) - - Y - - 
Amam (Vitiated Rasa formed during digestion) - - Y - - 
e. Rasavahasrotas 
Jwaram (Fever) Y Y Y Y Y 
Sramam (Fatigue) - - Y - - 
Swayadhu (Odoema) - - Y - - 
Kaphasopham (Odoema due to Kapha aggravation) - - Y - - 
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f. Raktavaha srotas 
Raktadosham (Disorders due to vitiated blood) Y - Y - Y 
Raktodrakam (Bleeding through small vessels) - - - - Y 
Hridayavidaham (Burning sensation in Heart) - - Y - - 
Pandu (Anaemia) Y - - Y - 
Kamila (Jaundice) Y - - - - 
Vatasram (Rhematoid arthritis) Y - - - - 
Raktavatam (Disorder due to aggravated Rakta and 
Vata) 
Y - - - - 
Raktapittam (Haemoptysis) - Y - - - 
Kushtam (Skin diseases) Y Y Y - - 
Kandu (Pruritis) Y - Y - - 
Visarpam (Erysipelas) Y Y - - - 
Visphotam (Blister) - Y - - - 
Sajwarabranti (Delirium) - - - - Y 
Bhramam (Vertigo) Y Y - - - 
Moham (Loss of consciouness) - Y - - - 
g. Mamsavahasrotas 
Vranam (Ulcer) - Y Y - Y 
Arsas (Piles) - - - Y - 
Raktarsas (Bleeding piles) Y - - - - 
h. Medovahasrotas 
Medas (Obesity) Y - - - - 
Meham (Diabetes) Y - Y - - 
i. Toxic condition 
Visham (Toxins) - Y - - Y 
Bahuvisham (severe toxicity) - - Y - - 
Pittavisham (Toxicity associated with vitiated Pitta) - - Y - - 
j. Condition of patient 
Arti (Pain due to illness) Y - - - - 
II. Agantuka vikaras (Exogenous diseases) 
Krimi (Macroscopic Pathogens like worms) Y Y - Y - 
Jantu (Small animals like insects, spider, etc) - - - - Y 
Bhootam (Micro organisms)  - - - Y 
Pharmacological Evaluation of Drugs 
Research studies of various extracts and phytoconstituents were used to evaluate the pharmacological 
activites of the drugs in Guduchyadi kwatham as mentioned in the table below. Clinical pharmacological 
approach and in vivo and in vitro experimental pharmacological methods were adopted to demonstrate the 
pharmacological activites. 
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Table 8: Extracts/Phytoconstituents that demonstrated Pharmacological activities of drugs in 
Guduchyadi kwatham 
Pharmacological 
activities 
Stem of 
Tinospora 
cordifolia  
*Heartwood of 
Prunus cerasoides/  
#Heartwood of 
Caesalpinia sappan 
Linn 
Stembark of 
Azadirachta 
indica 
Fruits of 
Coriandru
m sativum 
Heartwood 
of 
Pterocarpus 
santalinus 
Antiviral  #In vitro study- 
brazilein, brazilin, 
protosappanin A, 3-
deoxysappanchalcone, 
sappanchalcone and 
rhamnetin [16] 
In vitro study 
-Extract [29] 
  
Anti-dengue   In silico study 
- 
Triterpenoid 
constituents 
[30] 
  
Anti-HIV Clinical study – 
Extract[4] 
    
Antimalarial   In vivo study- 
Tablet 
suspension 
[31] 
  
Anti-
inflammatory 
In vivo study- 
Aqueous 
extract [5] 
 
#In vitro study - 
Brazilin [17] 
In vitro study 
- 
Nimbidin [32] 
In vivo 
study- 
Aqueous 
and 
ethanolic 
extracts [39] 
In vivo study- 
Methanolic 
extract [51] 
Antipyretic  In vivo study- 
Aqueous 
extract [5] 
  In vivo 
study- 
Extract [40] 
In vivo study- 
Aqueous 
extract [52] 
Analgesic  #In vivo study- 
Ethanol extract [18] 
In vivo study- 
Fresh juice 
[33] 
In vivo 
study- 
Aqueous 
extract [41] 
In vivo study- 
Methanolic 
extract [51] 
Antibacterial In vitro study - 
Ethanol 
extract [6] 
*In vitro study - 
Ethanolic extract [19] 
#In vitro studies - 
Chloroform, n-
butanol, methanol and 
aqueous extracts [20] 
In vitro study 
- Ethanol 
extract [34] 
In vitro 
study - 
Ethanolic 
extract [42] 
 
In vitro study 
- Methanolic 
extract [53] 
Antitubercular  #In vitro study - 
3-
deoxysappanchalcone 
from ethyl acetate 
solvent [21] 
   
Anti-allergic Clinical study – 
Extract [7] 
#In vivo study - 
Dichloromethane 
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extract [22] 
Antioxidant In vitro study- 
Hydro-
ethanolic 
extract [8] 
 
#In vitro study- 
Ethanol extract, 
protosappanin A, and 
protosappanin B [23] , 
Brazelien [24] 
In vitro 
study- 
Ethanol 
extract [35] 
In vitro 
study -  
Aqueous 
extract [43] 
In vitro study 
–  
Methanolic 
extract [51] 
Immuno-
modulatory 
In vitro study- 
Aqueous 
extract [9] 
    
Gastroprotective   In vivo study- 
Extract [36] 
In vivo 
study- 
Fruits [44] 
In vivo study- 
Alcoholic 
extract [54] 
Hepatoprotective Clinical study- 
extract [10] 
#In vivo study - 
methanol and 
aqueous extracts [25] 
In vivo – 
Nimbolide [37] 
 
  
Cardioprotective In vivo study - 
alcoholic 
extract [11] 
  In vivo 
study - 
hydro-
methanolic 
extract [45] 
 
Antidiabetic In vivo study - 
Aqueous and 
alcoholic 
extracts [12] 
#In vivo study- 
Ethanol extract [26] 
 In vivo 
study- 
Aqueous 
extract. [46] 
In vivo study- 
Aqueous 
extract [55] 
Hypolipidemic  In vivo study - 
aqueous and 
alcoholic 
extract [13] 
#In vivo study - 
Hydroalcoholic 
extract [27] 
 
 In vivo 
study – 
seeds [47] 
 
 
Anti cancerous In vitro study 
in HeLa cells - 
methanol, 
aqueous and 
methylene 
chloride [14] 
In vitro B16F-
10 melanoma 
cells - 
polysaccharide 
fraction [15] 
#In vitro study in 
human cervix HeLa 
adenocarcinoma, 
human lung A549 
adenocarcinoma, 
murine colon 26-L5 
carcinoma, murine 
Lewis lung carcinoma 
(LLC) and murine 
B16-BL6 melanoma 
cells- Methanol, 
methanol-water (1:1) 
and water extract [28]  
In vitro study 
in human 
hepatocarcin
oma (HepG2) 
cells - 
Nimbolide [38] 
In vivo 
study in 
colon 
cancer in 
rats – seeds 
[48] 
In vitro study 
in cancer cell 
lines -
Pterostilbene 
[56] 
 
Anxiolytic 
 
   In vivo 
study - 
aqueous 
extract [49] 
 
Antidepressant 
 
   In vivo 
study- 
Diethyl 
ether 
extract [50] 
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Benefits of Guduchyadi Kwatham in Coronavirus 
Disease (Covid-19) and its Pharmcodynamics  
Coronavirus disease 2019 (COVID-19) is 
caused by the severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2). SARS-CoV- 2 has been 
categorised as a HG3 organism like SARS-related and 
MERS-related corona viruses. Other viruses within 
HG3 include rabies, poliovirus, dengue virus, 
hepatitis virus B, C, D and E, and HIV 1 and 2. [57-59] 
The virus spreads from person to person 
through direct or indirect contact, droplet spray or 
aerosol. Hence COVID-19 is being thought as an 
airborne disease. The virus enters the body mainly 
through respiratory route, the disease starts 
manifesting with the symptoms of upper respiratory 
tract infection. The incubation period ranges from 2 
to 14 days after exposure. It is reported that in some 
case incubation period extends upto 28 days. 
Clinical spectrum of COVID-19 ranges from 
asymptomatic patients to septic shock and multi 
organ dysfunction. The most common symptoms at 
onset of COVID-19 illness are fever, cough, sputum 
production, fatigue, headache, haemoptysis, 
diarrhoea, dyspnoea, and lymphopenia. When the 
disease advances, clinical conditions like pneumonia, 
RNAaemia, acute respiratory distress syndrome, 
acute cardiac injury, and incidence of ground-glass 
opacities that lead to death may develop.[60-63] 
Based on the severity, the disease is classified 
into mild, moderate, severe, and critical. Patients 
with mild illness may present with symptoms of an 
upper respiratory tract viral infection that includes 
dry cough, mild fever, nasal congestion, sore throat, 
headache, muscle pain, and malaise. Dyspnoea is 
absent in such cases. The majority of COVID-19 cases 
are mild in severity. Patients with mild disease can 
quickly deteriorate into severe or critical cases. 
Patients with moderate illness present with 
respiratory symptoms of cough, shortness of breath, 
and tachypnea. Patients with severe disease present 
with severe pneumonia, acute respiratory distress 
syndrome (ARDS), sepsis, or septic shock. Patients 
with preexisting comorbidities like diabetes, 
respiratory disease, cardiovascular disease, 
hypertension, and oncological complications have a 
higher case fatality rate.[64,65]  
During pathogenesis infected person shows 
higher leukocyte numbers, abnormal respiratory 
findings and increased levels of plasma pro-
inflammatory cytokines. Significantly high blood 
levels of cytokines and chemokines is usually seen in 
patients with COVID-19 infection that included IL1-β, 
IL1RA, IL7, IL8, IL9, IL10, basic FGF2, GCSF, GMCSF, 
IFNγ, IP10, mMCP1, MIP1α, MIP1β, PDGFB, TNFα, 
and VEGFA. Sometimes, in severe cases, high levels 
pro-inflammatory cytokines including IL2, IL7, IL10, 
GCSF, IP10, MCP1, MIP1α, and TNFα may be 
observed.[61] Release of large amounts of pro-
inflammatory cytokines called ‘cytokine storm’ 
leading to deadly uncontrolled systemic 
inflammatory response is seen in individuals with 
severe COVID-19 infection. This is the cause of ARDS 
and multiple organ failure in severe cases.[66] 
Moreover recent studies report evidence of blood 
clotting pattern that causes micro-clots in lungs, 
brain and kidney in affected patients. 
Immune system is also seriously affected by 
the invasion of the virus. In order to survive in host 
cells, SARS-CoV use multiple mechanisms to avoid 
immune responses and that increases the virus load 
in the body. [67] 
Since COVID-19 is an infectious one, the main 
symptom seen in this disease is Jwaram (Fever). 
Because of the infection in the respiratory tract, 
symptoms like cough, sputum production, fatigue etc 
can be seen associated with fever. Diseases caused by 
exogenous factors are named as ‘Agantu’ in 
Ayurvedic classics. Jwaram or fever caused especially 
by microorganisms is grouped under ‘Abhishanga 
jwara’. It is described that abhishanga jwara is 
manifested with the vitiation of Vatapitta doshas.[68] 
On localization of the infection in Pranavahasrotas or 
respiratory tract, the symptoms of vitiated Kapha 
dosha like Kasam (Cough), Sputum (Kapham), etc 
manifests. While the infection advances, the virus 
causes organic damage of respiratory system and 
spreads all over the body through Rakta (Blood) by 
vitiating the same and producing the symptoms like 
haemoptysis, lymphopenia, RNAaemia, blood clots 
and acute cardiac injury. 
When the symptoms and pathogenesis of 
COVID-19 is considered it may be assumed that the 
main Doshas involved in the development of disease 
are Pitta and Kapha. The involvment of Vata dosha 
can also be assumed from the symptoms manifested 
like dyspnoea and tachypnea in moderate and acute 
respiratory distress syndrome (ARDS) and septic 
shock in severe cases.  
The formulation ‘Guduchyadi kwatham’ is 
indicated mainly for diseases caused by vitiation of 
Pitta and Kapha doshas. Since the formulation 
pacifies Jwara, it is beneficial in the symptoms fever, 
loss of appetite and malaise caused in the onset of the 
disease. The drugs in the formulation together works 
and act as a ‘Deepana’ medicine, i.e., improve the 
digestive power. Two of the ingredients, Guduchi and 
Dhanyaka digest Amam – i.e., vitiated ‘Rasa’ formed 
during digestion and impede the manifestation of 
Jwara.  
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On analyzing the therapeutic indications of 
individual drugs it can be recognized that the 
formulation is beneficial in disorders of respiratory 
system, such as Kasam (Cough) and Swasam 
(Dyspnoea). The drugs Guduchi, Arishta, Dhanyaka 
and Raktachandana are indicated for Kasam and 
Arishta and Dhanyakam for Swasam. The 
predominance of the Rasas (Taste), Katu (Acrid) 
Tikta (Bitter) and Kashaya (Astringent) of these 
drugs helps to check the production of mucus in the 
lungs and thereby dyspnoea due to occlusion of 
alveoli. [69] 
The medicine is very much beneficial in 
diseases due to vitiation of Raktavahasrotas due to 
‘Amam’. Diseases that manifest through Rakta 
(Blood) can be controlled by the drugs Guduchi, 
Arishta and Raktachandana as they possess blood 
purifiying property (Raktasudhi) and are indicated as 
a remedy for diseases due to blood vitiation 
(Raktadosham). Since Raktachandana pacifies 
Raktodrekam (bleeding through small vessels) the 
formulation can be effectively used for preventing the 
formation of blood clots and Haemoptysis. 
All drugs in the formulation are beneficial for 
alleivating the gastrointestinal symptoms, Chardhi 
(Emesis) and Trid (thirst). Drugs, Guduchi and 
Padmaka are stipulated for Bhramam (distress) and 
Rakachandana is especially for Bhramam associated 
with Fever. Guduchi particularly checks the agony 
(Arti) caused by the disease. Guduchi, Padmaka, 
Dhanyaka and Raktachandana are useful against 
macroscopic pathogens (Krimi) and Raktachandana 
in particular for micro organisams (Bhootam). Drugs 
Padmaka, Arishta and Raktachandana are remedies 
for toxic manifestations (Visham) and hence they can 
work to prevent toxemic manifestion of the disease. 
Property like Hridyam (beneficial effect on heart) and 
effectiveness of the drugs in Meham (Diabetes) helps 
as a remedy for comorbid states of metabolic 
disorders and cardiovascular system. 
Pharmacological evaluation suggests that 
Tinospora cordifolia possess anti-HIV activity and 
Azadirachta indica possess anti dengue activity. 
Caesalpinia sappan and Azadirachta indica 
demonstrated antiviral activity. All the drugs in the 
formulation found with the potential of anti- 
inflammatory action and antibacterial effect against 
respiratory pathogens. Tinospora cordifolia, 
Coriandrum sativum and Pterocarpus santalinus 
possess potent antipyretic activity. Anti malarial 
activity of Azadirachta indica was also demonstrated. 
All the drugs are antioxidant in nature and there by 
checks the oxidative stress to various tissues of the 
body. Tinospora cordifolia can be seen as an effective 
immunomodulator in the formulation. Tinospora 
cordifolia, Coriandrum sativum and Pterocarpus 
santalinus possess anti diabetic property. Most of the 
drugs have gastroprotective, hepatoprotective and 
cardioprotective activities. All drugs demonstrated 
anti-cancerous activity during in vitro studies. 
Pharmcological actions like hypolipidemic, Anxiolytic 
and antidepressant are the other benefits of the 
drugs in this formulation. 
Main action of the formulation is in vitiated 
Pittakapha condition, and symptoms of vitiated 
Pranavahasrotas, Annavahasrotas, Rasavahasrotas 
and Raktavahasrotas. This formulation is good to 
administer even in Agnimandya (poor digestive fire) 
condition since the formulation, ie kwatha kalpana 
(decoction) as such and the individual drugs are 
Laghu (Light) in quality. Considering the above 
validated effects, it can be suggested that Guduchyadi 
kwatham is a useful medicine to prevent viral 
diseases upto certain extent. It is also effective in 
protecting Pranavahasrotas (respiratory system) 
Annavahasrotas (Gastrointestinal system), 
Udakavahasrotas (channels of fluid), Rasavahasrotas 
(Plasma and Lymphatic system) and Raktavahasrotas 
(Blood and Cardiovascular system). It can be used as 
a prophylactic measure for persons in containment 
zone and to treat exposed and mild cases of COVID-
19. This medicine may also be valuable as an addon 
drug with conventional treatment approach in 
moderate cases. The screened activities of the drugs 
support the use of this medicine in comorbidities like 
Diabetes, Gastric ulcer, Jaundice, Cardiac diseases, 
Hyperlipidemia, Cancer, Anxiety and Depression. 
CONCLUSION 
COVID-19 is an airborne disease that affects 
the respiratory system. Infection generates 
leukocytosis and high levels pro-inflammatory 
cytokines and chemokines in plasma. It is the 
‘cytokine storm’ that leads to acute respiratory 
distress syndrome (ARDS) in severe cases. The initial 
step needed in the management of SARS-CoV- 2 
infection is prevention of inflammatory process and 
alleviation of respiratory symptoms. So, unique 
concern is necessary to check ‘Pitta dosha’ and 
‘Kapha dosha’ aggravation.  
Guduchyadi kwatham is a well known 
formulation used in the treatment of diseases due to 
Pitta and Kapha dosa vitiation. It is indicated in 
Jwaram (Fever) and the individual drugs in the 
formulation, signifies the benefit in Pranavahasotas, 
Annavahasrotas, Udakavahasrotas, Rasavahasrotas 
and Raktavahasrotas. Demonstrated pharmacological 
activities like anti-inflammatory, antipyretic, 
antiviral, anti-bacterial, anti allergic, etc substantiate 
the use of this medicine in the prevention and 
mitigation of this viral disease. 
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